Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations
Open Access
- 1 September 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 44 (9) , 1931-1936
- https://doi.org/10.1093/clinchem/44.9.1931
Abstract
Melatonin has been suggested as a potent antioxidant that may protect against development of atherosclerosis and cancer; however, these effects are unproven and controversial. The antioxidant capacity of melatonin was tested in comparison with α-tocopherol, ascorbic acid, and the melatonin precursors tryptophan and serotonin, by measuring inhibition of metal ion-mediated and human macrophage-mediated oxidation of LDL. Melatonin had weak antioxidant activity that was detectable only at concentrations 10 000- to 100 000-fold higher than physiologic concentrations. These results were comparable with published data showing that the radical scavenging activity of melatonin requires markedly supraphysiologic concentrations. In contrast, α-tocopherol was 50- to 100-fold more potent and was efficacious at physiologic concentrations. Ascorbic acid and tryptophan also were active at physiologic concentrations and were significantly more potent than melatonin. In summary, extremely supraphysiologic concentrations of melatonin had only weak antioxidant activity, which was surpassed by α-tocopherol, ascorbic acid, and tryptophan.Keywords
This publication has 43 references indexed in Scilit:
- Effect of melatonin and metabolites on copper‐mediated oxidation of low density lipoproteinBritish Journal of Clinical Pharmacology, 1997
- Melatonin Protects LDL from Oxidation but Does Not Prevent the Apolipoprotein DerivatizationBiochemical and Biophysical Research Communications, 1996
- The Role of Dietary Antioxidants in Prevention of AtherosclerosisThe Endocrinologist, 1995
- Light Treatment for Sleep Disorders: Consensus ReportJournal of Biological Rhythms, 1995
- The Effect of α-Tocopherol Supplementation on LDL OxidationArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The role of melatonin and serotonin in aging: UpdatePsychoneuroendocrinology, 1993
- Melatonin, hydroxyl radical‐mediated oxidative damage, and aging: A hypothesisJournal of Pineal Research, 1993
- Aging-Postponing Effects of Orcadian Melatonin: Experimental Evidence, Significance and Possible MechanismsInternational Journal of Neuroscience, 1990
- A Pharmacological Dose of Melatonin Increases PRL Levels in Males without Altering Those of GH, LH, FSH, TSH, Testosterone or CortisolNeuroendocrinology, 1987
- A secretory product of human monocyte-derived macrophages stimulates low density lipoprotein receptor activity in arterial smooth muscle cells and skin fibroblasts.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982